- Goldman Sachs has revealed a $500M Bitcoin stake, diversifying across major ETFs.
- Michael Saylor’s MicroStrategy held 226,500 BTC, highlighting Bitcoin’s growing corporate appeal.
As Bitcoin [BTC] approaches the $60K mark, exciting news has emerged from the cryptocurrency world.
Goldman Sachs’ Bitcoin holdings revealed
Dennis Porter, CEO and co-founder of SatoshiActFund, recently took to Twitter to reveal that Goldman Sachs has disclosed a significant $500 million stake in Bitcoin.
He added,
“Even the bankers cannot resist Bitcoin.”
Porter also provided a detailed analysis of Goldman Sachs’ Bitcoin holdings.
According to a quarterly 13F filing, Goldman Sachs holds positions in seven out of the eleven Bitcoin ETFs available in the U.S.
The bank’s largest investment is in the iShares Bitcoin Trust (IBIT), with a substantial stake of $238.6 million.
This is followed by Fidelity’s Bitcoin ETF (FBTC) at $79.5 million, Invesco Galaxy’s BTC ETF (BTCO) at $56.1 million, and Grayscale’s GBTC at $35.1 million.
Goldman Sachs also maintains smaller holdings in BITB, BTCW, and ARKB, reflecting a broad and strategic approach to Bitcoin investments.
Source: Dennis Porter/X
Bitcoin ETF update
In the meantime, on the 13th of August, Bitcoin ETFs experienced a notable influx of capital, with total inflows amounting to $39 million as per Farside Investors.
Leading the charge was BlackRock’s IBIT, which saw substantial inflows of $34.6 million. Fidelity’s FBTC further followed it with $22.6 million, while Bitwise’s BITB attracted $16.5 million.
In contrast, Grayscale’s GBTC faced outflows totaling $28.6 million, followed by ARK 21Shares’ ARKB totaling $6.1 million. The remaining ETFs saw no significant changes.
This divergence in ETF performance highlights shifting investor sentiment within the Bitcoin market.
Michael Saylor’s BTC holdings uncovered
That being said, Goldman Sachs isn’t the only major player revealing its Bitcoin holdings. Michael Saylor, co-founder and chairman of MicroStrategy, recently disclosed that he owns 17,732 BTC.
Notably, Saylor emphasized that he has retained every single one of these digital assets, without selling any.
“I continue to acquire more. I think it’s a great capital investment asset for an individual, family, institutional corporation or country. I can’t see a better place to put my money.”
In addition to Michael Saylor’s personal Bitcoin stash, MicroStrategy holds 226,500 BTC, valued at around $12.7 billion, making it the largest public corporate Bitcoin holder.
What’s changed?
This landscape underscores how Bitcoin ETFs have transformed Bitcoin and the broader crypto market. Yet, this stands in stark contrast to Goldman Sachs’ earlier stance on digital assets.
In April, Sharmin Mossavar-Rahmani, chief investment officer of Goldman Sachs Wealth Management for the past 23 years, reiterated to the Wall Street Journal and said,
“We do not think it is an investment asset class. We’re not believers in crypto.”
- Goldman Sachs has revealed a $500M Bitcoin stake, diversifying across major ETFs.
- Michael Saylor’s MicroStrategy held 226,500 BTC, highlighting Bitcoin’s growing corporate appeal.
As Bitcoin [BTC] approaches the $60K mark, exciting news has emerged from the cryptocurrency world.
Goldman Sachs’ Bitcoin holdings revealed
Dennis Porter, CEO and co-founder of SatoshiActFund, recently took to Twitter to reveal that Goldman Sachs has disclosed a significant $500 million stake in Bitcoin.
He added,
“Even the bankers cannot resist Bitcoin.”
Porter also provided a detailed analysis of Goldman Sachs’ Bitcoin holdings.
According to a quarterly 13F filing, Goldman Sachs holds positions in seven out of the eleven Bitcoin ETFs available in the U.S.
The bank’s largest investment is in the iShares Bitcoin Trust (IBIT), with a substantial stake of $238.6 million.
This is followed by Fidelity’s Bitcoin ETF (FBTC) at $79.5 million, Invesco Galaxy’s BTC ETF (BTCO) at $56.1 million, and Grayscale’s GBTC at $35.1 million.
Goldman Sachs also maintains smaller holdings in BITB, BTCW, and ARKB, reflecting a broad and strategic approach to Bitcoin investments.
Source: Dennis Porter/X
Bitcoin ETF update
In the meantime, on the 13th of August, Bitcoin ETFs experienced a notable influx of capital, with total inflows amounting to $39 million as per Farside Investors.
Leading the charge was BlackRock’s IBIT, which saw substantial inflows of $34.6 million. Fidelity’s FBTC further followed it with $22.6 million, while Bitwise’s BITB attracted $16.5 million.
In contrast, Grayscale’s GBTC faced outflows totaling $28.6 million, followed by ARK 21Shares’ ARKB totaling $6.1 million. The remaining ETFs saw no significant changes.
This divergence in ETF performance highlights shifting investor sentiment within the Bitcoin market.
Michael Saylor’s BTC holdings uncovered
That being said, Goldman Sachs isn’t the only major player revealing its Bitcoin holdings. Michael Saylor, co-founder and chairman of MicroStrategy, recently disclosed that he owns 17,732 BTC.
Notably, Saylor emphasized that he has retained every single one of these digital assets, without selling any.
“I continue to acquire more. I think it’s a great capital investment asset for an individual, family, institutional corporation or country. I can’t see a better place to put my money.”
In addition to Michael Saylor’s personal Bitcoin stash, MicroStrategy holds 226,500 BTC, valued at around $12.7 billion, making it the largest public corporate Bitcoin holder.
What’s changed?
This landscape underscores how Bitcoin ETFs have transformed Bitcoin and the broader crypto market. Yet, this stands in stark contrast to Goldman Sachs’ earlier stance on digital assets.
In April, Sharmin Mossavar-Rahmani, chief investment officer of Goldman Sachs Wealth Management for the past 23 years, reiterated to the Wall Street Journal and said,
“We do not think it is an investment asset class. We’re not believers in crypto.”
buying generic clomid without prescription order clomiphene pill generic clomiphene walmart cost of cheap clomid without rx where can i get generic clomiphene no prescription clomiphene challenge test protocol clomid generico
I’ll certainly bring to skim more.
More articles like this would frame the blogosphere richer.
azithromycin pills – buy tetracycline online purchase flagyl generic
rybelsus pill – buy semaglutide 14mg sale order cyproheptadine 4mg generic
domperidone brand – cyclobenzaprine 15mg cheap where can i buy cyclobenzaprine
augmentin sale – atbioinfo buy acillin sale
nexium buy online – anexa mate buy esomeprazole cheap
purchase warfarin – https://coumamide.com/ buy hyzaar no prescription
mobic 7.5mg drug – https://moboxsin.com/ buy meloxicam 15mg without prescription
prednisone tablet – apreplson.com order deltasone 5mg online cheap
erectile dysfunction pills over the counter – https://fastedtotake.com/ cheap erectile dysfunction pills online
buy amoxil pills for sale – https://combamoxi.com/ amoxicillin pills
generic forcan – buy generic forcan over the counter order diflucan sale
order cenforce 100mg for sale – https://cenforcers.com/# where to buy cenforce without a prescription
cheap cialis dapoxitine cheap online – https://ciltadgn.com/# buy tadalafil cheap online
buy cheap tadalafil online – https://strongtadafl.com/# cheap cialis canada
brand zantac 300mg – https://aranitidine.com/# zantac tablet
buy viagra generic usa – strong vpls buy viagra in amsterdam
Thanks for putting this up. It’s understandably done. que es prednisolone
More posts like this would prosper the blogosphere more useful. prednisone and fluid retention
Thanks on putting this up. It’s evidently done. https://ursxdol.com/levitra-vardenafil-online/
Thanks on putting this up. It’s evidently done. https://prohnrg.com/product/diltiazem-online/
This is a theme which is virtually to my fundamentals… Diverse thanks! Unerringly where can I upon the acquaintance details in the course of questions? https://aranitidine.com/fr/sibelium/
Thanks on putting this up. It’s understandably done. https://ondactone.com/simvastatin/
Thanks towards putting this up. It’s understandably done.
https://doxycyclinege.com/pro/warfarin/